サマリー

世界のSplit Influenza Vaccineの市場規模は、2022年の100万米ドルから2029年には100万米ドルになると予測されており、2023年から2029年にかけてCAGR %で成長することが見込まれています。
分割型インフルエンザワクチンの米国市場は、2023年から2029年までのCAGR %で、2022年の100万米ドルから2029年には100万米ドルに増加すると予測されています。
分割型インフルエンザワクチンの中国市場は、2023年から2029年にかけてのCAGRで、2022年の100万米ドルから2029年には100万米ドルに増加すると推定されます。
分割型インフルエンザワクチンのヨーロッパ市場は、2023年から2029年にかけてのCAGR %で、2022年の100万米ドルから2029年には100万米ドルに増加すると推定されます。
世界の主要なSplit Influenza Vaccineプレーヤーは、Sanofi Pasteur、CSL Seqirus、GSK、Sequirus, Inc、straZenecaおよびDalian Yali Peakなどをカバーしています。収益面では、世界の2大企業が2022年にほぼ％のシェアを占めています。
インフルエンザウイルス分割ワクチンは、世界保健機関（WHO）が推奨し、国家薬品管理部門が承認したインフルエンザウイルス株を鶏胚に接種し、培養、採取したウイルス液、ウイルス不活性化、精製、分解して製造されています。このタイプのウイルスによるインフルエンザの予防に。
LPI（エルピーアイ）の最新リサーチレポート「分割型インフルエンザワクチン産業予測」は、過去の販売実績から2022年の世界の分割型インフルエンザワクチンの総販売実績を検証し、2023年から2029年の分割型インフルエンザワクチンの販売予測について地域や市場分野ごとに包括的に分析しています。本レポートでは、分割型インフルエンザワクチンの売上を地域別、市場分野別、サブセクター別に分類し、世界の分割型インフルエンザワクチン産業の詳細な分析（百万米ドル）を提供します。
本インサイトレポートでは、世界のSplit Influenza Vaccineの状況を包括的に分析し、製品区分、会社設立、収益、市場シェア、最新開発、M&A活動に関する主要トレンドを明らかにしています。また、本レポートでは、加速する世界のSplit Influenza Vaccine市場におけるこれらの企業の独自のポジションをより理解するために、Split Influenza Vaccineのポートフォリオと能力、市場参入戦略、市場ポジション、地理的フットプリントに焦点を当てて、主要グローバル企業の戦略を分析しています。
本インサイトレポートでは、分割型インフルエンザワクチンの世界的な見通しを形成する主要な市場動向、推進要因、影響要因を評価し、タイプ別、用途別、地域別、市場規模別に予測を行い、新たな機会のポケットを明らかにします。何百ものボトムアップの定性的・定量的な市場インプットに基づく透明性の高い手法により、本調査予測は、世界のSplit Influenza Vaccineにおける現状と将来の軌道について非常にニュアンスのある見方を提供します。
本レポートでは、製品タイプ、用途、主要メーカー、主要地域・国別の分割型インフルエンザワクチン市場の包括的な概要、市場シェア、成長機会について紹介します。
市場のセグメンテーション
タイプ別セグメンテーション
アルダルト
子
用途別セグメンテーション
病院
診療所
また、本レポートでは、地域別に市場を分割しています：
米州
アメリカ
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
欧州
ドイツ
フランス
イギリス
イタリア
ロシア
中近東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家から収集した情報、企業のカバレッジ、製品ポートフォリオ、市場浸透度を分析した上で選定されています。
サノフィ・パストゥール
CSL Seqirus
GSK
Seqirus, Inc.
ストラゼネカ
大連亞里峰
本レポートで取り上げる主な質問
世界のSplit Influenza Vaccine市場の10年後の見通しは？
世界および地域別で、分割型インフルエンザワクチン市場の成長を促進する要因は何か？
市場別、地域別で最も速い成長を遂げる技術は何か？
分割型インフルエンザワクチンの市場機会は、エンドマーケットの規模によってどのように変化するのか？
分割型インフルエンザワクチンのタイプ別、用途別内訳は？
COVID-19とロシア・ウクライナ戦争の影響とは？

ページTOPに戻る

目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Split Influenza Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Split Influenza Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Split Influenza Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Split Influenza Vaccine Segment by Type
2.2.1 Aldult
2.2.2 Child
2.3 Split Influenza Vaccine Sales by Type
2.3.1 Global Split Influenza Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Split Influenza Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Split Influenza Vaccine Sale Price by Type (2018-2023)
2.4 Split Influenza Vaccine Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Split Influenza Vaccine Sales by Application
2.5.1 Global Split Influenza Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Split Influenza Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Split Influenza Vaccine Sale Price by Application (2018-2023)
3 Global Split Influenza Vaccine by Company
3.1 Global Split Influenza Vaccine Breakdown Data by Company
3.1.1 Global Split Influenza Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Split Influenza Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Split Influenza Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Split Influenza Vaccine Revenue by Company (2018-2023)
3.2.2 Global Split Influenza Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Split Influenza Vaccine Sale Price by Company
3.4 Key Manufacturers Split Influenza Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Split Influenza Vaccine Product Location Distribution
3.4.2 Players Split Influenza Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Split Influenza Vaccine by Geographic Region
4.1 World Historic Split Influenza Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Split Influenza Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Split Influenza Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Split Influenza Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Split Influenza Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Split Influenza Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Split Influenza Vaccine Sales Growth
4.4 APAC Split Influenza Vaccine Sales Growth
4.5 Europe Split Influenza Vaccine Sales Growth
4.6 Middle East & Africa Split Influenza Vaccine Sales Growth
5 Americas
5.1 Americas Split Influenza Vaccine Sales by Country
5.1.1 Americas Split Influenza Vaccine Sales by Country (2018-2023)
5.1.2 Americas Split Influenza Vaccine Revenue by Country (2018-2023)
5.2 Americas Split Influenza Vaccine Sales by Type
5.3 Americas Split Influenza Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Split Influenza Vaccine Sales by Region
6.1.1 APAC Split Influenza Vaccine Sales by Region (2018-2023)
6.1.2 APAC Split Influenza Vaccine Revenue by Region (2018-2023)
6.2 APAC Split Influenza Vaccine Sales by Type
6.3 APAC Split Influenza Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Split Influenza Vaccine by Country
7.1.1 Europe Split Influenza Vaccine Sales by Country (2018-2023)
7.1.2 Europe Split Influenza Vaccine Revenue by Country (2018-2023)
7.2 Europe Split Influenza Vaccine Sales by Type
7.3 Europe Split Influenza Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Split Influenza Vaccine by Country
8.1.1 Middle East & Africa Split Influenza Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Split Influenza Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Split Influenza Vaccine Sales by Type
8.3 Middle East & Africa Split Influenza Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Split Influenza Vaccine
10.3 Manufacturing Process Analysis of Split Influenza Vaccine
10.4 Industry Chain Structure of Split Influenza Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Split Influenza Vaccine Distributors
11.3 Split Influenza Vaccine Customer
12 World Forecast Review for Split Influenza Vaccine by Geographic Region
12.1 Global Split Influenza Vaccine Market Size Forecast by Region
12.1.1 Global Split Influenza Vaccine Forecast by Region (2024-2029)
12.1.2 Global Split Influenza Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Split Influenza Vaccine Forecast by Type
12.7 Global Split Influenza Vaccine Forecast by Application
13 Key Players Analysis
13.1 Sanofi Pasteur
13.1.1 Sanofi Pasteur Company Information
13.1.2 Sanofi Pasteur Split Influenza Vaccine Product Portfolios and Specifications
13.1.3 Sanofi Pasteur Split Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Sanofi Pasteur Main Business Overview
13.1.5 Sanofi Pasteur Latest Developments
13.2 CSL Seqirus
13.2.1 CSL Seqirus Company Information
13.2.2 CSL Seqirus Split Influenza Vaccine Product Portfolios and Specifications
13.2.3 CSL Seqirus Split Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 CSL Seqirus Main Business Overview
13.2.5 CSL Seqirus Latest Developments
13.3 GSK
13.3.1 GSK Company Information
13.3.2 GSK Split Influenza Vaccine Product Portfolios and Specifications
13.3.3 GSK Split Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 GSK Main Business Overview
13.3.5 GSK Latest Developments
13.4 Seqirus, Inc.
13.4.1 Seqirus, Inc. Company Information
13.4.2 Seqirus, Inc. Split Influenza Vaccine Product Portfolios and Specifications
13.4.3 Seqirus, Inc. Split Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Seqirus, Inc. Main Business Overview
13.4.5 Seqirus, Inc. Latest Developments
13.5 straZeneca
13.5.1 straZeneca Company Information
13.5.2 straZeneca Split Influenza Vaccine Product Portfolios and Specifications
13.5.3 straZeneca Split Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 straZeneca Main Business Overview
13.5.5 straZeneca Latest Developments
13.6 Dalian Yali Peak
13.6.1 Dalian Yali Peak Company Information
13.6.2 Dalian Yali Peak Split Influenza Vaccine Product Portfolios and Specifications
13.6.3 Dalian Yali Peak Split Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Dalian Yali Peak Main Business Overview
13.6.5 Dalian Yali Peak Latest Developments
14 Research Findings and Conclusion

ページTOPに戻る

図表リスト

List of Tables
Table 1. Split Influenza Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Split Influenza Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Aldult
Table 4. Major Players of Child
Table 5. Global Split Influenza Vaccine Sales by Type (2018-2023) & (K Units)
Table 6. Global Split Influenza Vaccine Sales Market Share by Type (2018-2023)
Table 7. Global Split Influenza Vaccine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Split Influenza Vaccine Revenue Market Share by Type (2018-2023)
Table 9. Global Split Influenza Vaccine Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Split Influenza Vaccine Sales by Application (2018-2023) & (K Units)
Table 11. Global Split Influenza Vaccine Sales Market Share by Application (2018-2023)
Table 12. Global Split Influenza Vaccine Revenue by Application (2018-2023)
Table 13. Global Split Influenza Vaccine Revenue Market Share by Application (2018-2023)
Table 14. Global Split Influenza Vaccine Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Split Influenza Vaccine Sales by Company (2018-2023) & (K Units)
Table 16. Global Split Influenza Vaccine Sales Market Share by Company (2018-2023)
Table 17. Global Split Influenza Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Split Influenza Vaccine Revenue Market Share by Company (2018-2023)
Table 19. Global Split Influenza Vaccine Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Split Influenza Vaccine Producing Area Distribution and Sales Area
Table 21. Players Split Influenza Vaccine Products Offered
Table 22. Split Influenza Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Split Influenza Vaccine Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Split Influenza Vaccine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Split Influenza Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Split Influenza Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Split Influenza Vaccine Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Split Influenza Vaccine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Split Influenza Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Split Influenza Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Split Influenza Vaccine Sales by Country (2018-2023) & (K Units)
Table 34. Americas Split Influenza Vaccine Sales Market Share by Country (2018-2023)
Table 35. Americas Split Influenza Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Split Influenza Vaccine Revenue Market Share by Country (2018-2023)
Table 37. Americas Split Influenza Vaccine Sales by Type (2018-2023) & (K Units)
Table 38. Americas Split Influenza Vaccine Sales by Application (2018-2023) & (K Units)
Table 39. APAC Split Influenza Vaccine Sales by Region (2018-2023) & (K Units)
Table 40. APAC Split Influenza Vaccine Sales Market Share by Region (2018-2023)
Table 41. APAC Split Influenza Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Split Influenza Vaccine Revenue Market Share by Region (2018-2023)
Table 43. APAC Split Influenza Vaccine Sales by Type (2018-2023) & (K Units)
Table 44. APAC Split Influenza Vaccine Sales by Application (2018-2023) & (K Units)
Table 45. Europe Split Influenza Vaccine Sales by Country (2018-2023) & (K Units)
Table 46. Europe Split Influenza Vaccine Sales Market Share by Country (2018-2023)
Table 47. Europe Split Influenza Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Split Influenza Vaccine Revenue Market Share by Country (2018-2023)
Table 49. Europe Split Influenza Vaccine Sales by Type (2018-2023) & (K Units)
Table 50. Europe Split Influenza Vaccine Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Split Influenza Vaccine Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Split Influenza Vaccine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Split Influenza Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Split Influenza Vaccine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Split Influenza Vaccine Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Split Influenza Vaccine Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Split Influenza Vaccine
Table 58. Key Market Challenges & Risks of Split Influenza Vaccine
Table 59. Key Industry Trends of Split Influenza Vaccine
Table 60. Split Influenza Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Split Influenza Vaccine Distributors List
Table 63. Split Influenza Vaccine Customer List
Table 64. Global Split Influenza Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Split Influenza Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Split Influenza Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Split Influenza Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Split Influenza Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Split Influenza Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Split Influenza Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Split Influenza Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Split Influenza Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Split Influenza Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Split Influenza Vaccine Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Split Influenza Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Split Influenza Vaccine Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Split Influenza Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Sanofi Pasteur Basic Information, Split Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Sanofi Pasteur Split Influenza Vaccine Product Portfolios and Specifications
Table 80. Sanofi Pasteur Split Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Sanofi Pasteur Main Business
Table 82. Sanofi Pasteur Latest Developments
Table 83. CSL Seqirus Basic Information, Split Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. CSL Seqirus Split Influenza Vaccine Product Portfolios and Specifications
Table 85. CSL Seqirus Split Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. CSL Seqirus Main Business
Table 87. CSL Seqirus Latest Developments
Table 88. GSK Basic Information, Split Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. GSK Split Influenza Vaccine Product Portfolios and Specifications
Table 90. GSK Split Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. GSK Main Business
Table 92. GSK Latest Developments
Table 93. Seqirus, Inc. Basic Information, Split Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Seqirus, Inc. Split Influenza Vaccine Product Portfolios and Specifications
Table 95. Seqirus, Inc. Split Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Seqirus, Inc. Main Business
Table 97. Seqirus, Inc. Latest Developments
Table 98. straZeneca Basic Information, Split Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. straZeneca Split Influenza Vaccine Product Portfolios and Specifications
Table 100. straZeneca Split Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. straZeneca Main Business
Table 102. straZeneca Latest Developments
Table 103. Dalian Yali Peak Basic Information, Split Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Dalian Yali Peak Split Influenza Vaccine Product Portfolios and Specifications
Table 105. Dalian Yali Peak Split Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Dalian Yali Peak Main Business
Table 107. Dalian Yali Peak Latest Developments
List of Figures
Figure 1. Picture of Split Influenza Vaccine
Figure 2. Split Influenza Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Split Influenza Vaccine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Split Influenza Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Split Influenza Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Aldult
Figure 10. Product Picture of Child
Figure 11. Global Split Influenza Vaccine Sales Market Share by Type in 2022
Figure 12. Global Split Influenza Vaccine Revenue Market Share by Type (2018-2023)
Figure 13. Split Influenza Vaccine Consumed in Hospital
Figure 14. Global Split Influenza Vaccine Market: Hospital (2018-2023) & (K Units)
Figure 15. Split Influenza Vaccine Consumed in Clinic
Figure 16. Global Split Influenza Vaccine Market: Clinic (2018-2023) & (K Units)
Figure 17. Global Split Influenza Vaccine Sales Market Share by Application (2022)
Figure 18. Global Split Influenza Vaccine Revenue Market Share by Application in 2022
Figure 19. Split Influenza Vaccine Sales Market by Company in 2022 (K Units)
Figure 20. Global Split Influenza Vaccine Sales Market Share by Company in 2022
Figure 21. Split Influenza Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Split Influenza Vaccine Revenue Market Share by Company in 2022
Figure 23. Global Split Influenza Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Split Influenza Vaccine Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Split Influenza Vaccine Sales 2018-2023 (K Units)
Figure 26. Americas Split Influenza Vaccine Revenue 2018-2023 ($ Millions)
Figure 27. APAC Split Influenza Vaccine Sales 2018-2023 (K Units)
Figure 28. APAC Split Influenza Vaccine Revenue 2018-2023 ($ Millions)
Figure 29. Europe Split Influenza Vaccine Sales 2018-2023 (K Units)
Figure 30. Europe Split Influenza Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Split Influenza Vaccine Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Split Influenza Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Americas Split Influenza Vaccine Sales Market Share by Country in 2022
Figure 34. Americas Split Influenza Vaccine Revenue Market Share by Country in 2022
Figure 35. Americas Split Influenza Vaccine Sales Market Share by Type (2018-2023)
Figure 36. Americas Split Influenza Vaccine Sales Market Share by Application (2018-2023)
Figure 37. United States Split Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Split Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Split Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Split Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Split Influenza Vaccine Sales Market Share by Region in 2022
Figure 42. APAC Split Influenza Vaccine Revenue Market Share by Regions in 2022
Figure 43. APAC Split Influenza Vaccine Sales Market Share by Type (2018-2023)
Figure 44. APAC Split Influenza Vaccine Sales Market Share by Application (2018-2023)
Figure 45. China Split Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Split Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Split Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Split Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Split Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Split Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Split Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Split Influenza Vaccine Sales Market Share by Country in 2022
Figure 53. Europe Split Influenza Vaccine Revenue Market Share by Country in 2022
Figure 54. Europe Split Influenza Vaccine Sales Market Share by Type (2018-2023)
Figure 55. Europe Split Influenza Vaccine Sales Market Share by Application (2018-2023)
Figure 56. Germany Split Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Split Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Split Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Split Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Split Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Split Influenza Vaccine Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Split Influenza Vaccine Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Split Influenza Vaccine Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Split Influenza Vaccine Sales Market Share by Application (2018-2023)
Figure 65. Egypt Split Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Split Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Split Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Split Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Split Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Split Influenza Vaccine in 2022
Figure 71. Manufacturing Process Analysis of Split Influenza Vaccine
Figure 72. Industry Chain Structure of Split Influenza Vaccine
Figure 73. Channels of Distribution
Figure 74. Global Split Influenza Vaccine Sales Market Forecast by Region (2024-2029)
Figure 75. Global Split Influenza Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Split Influenza Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Split Influenza Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Split Influenza Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Split Influenza Vaccine Revenue Market Share Forecast by Application (2024-2029)